Tools
Tools
Shrestha, Sunil, Khatri, Januka, Shakya, Sujyoti, Danekhu, Krisha, Khatiwada, Asmita Priyadarshini, Sah, Ranjit, Kc, Bhuvan, Paudyal, Vibhu, Khanal, Saval 
ORCID: https://orcid.org/0000-0001-5201-0612 and Rodriguez-Morales, Alfonso J.
(2021)
Adverse events related to COVID-19 vaccines: The need to strengthen pharmacovigilance monitoring systems.
Drugs & Therapy Perspectives, 37 (8).
pp. 376-382.
ISSN 1172-0360
Abstract
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new species of β-coronavirus genus named severe acute respiratory syndrome coronavirus 2. The COVID-19 pandemic, which started in late 2019 and continues as at mid-2021, has caused enormous damage to health and lives globally. The urgent public health need has led to the development of vaccines against COVID-19 in record-breaking time. The COVID-19 vaccines have been widely rolled out for the masses by many countries following approval for emergency use by the World Health Organization and regulatory agencies in many countries. In addition, several COVID-19 vaccine candidates are undergoing clinical trials. However, myths, fears, rumors, and misconceptions persist, particularly in regard to adverse events. In this commentary, we describe the adverse events associated with COVID-19 vaccines and discuss why it is essential to have a functional adverse event monitoring system in this context.
| Item Type: | Article |
|---|---|
| Additional Information: | Publisher Copyright: © 2021, The Author(s), under exclusive licence to Springer Nature Switzerland AG. |
| Uncontrolled Keywords: | pharmacology (medical),sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/2700/2736 |
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
| Related URLs: | |
| Depositing User: | LivePure Connector |
| Date Deposited: | 17 Apr 2023 15:30 |
| Last Modified: | 17 Apr 2023 16:30 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/91815 |
| DOI: | 10.1007/s40267-021-00852-z |
Actions (login required)
 |
View Item |